NICE drug wars: Tarceva vs Iressa, Revlimid vs IFN alpha, Botox vs SoC, and others
15 August 2011
Francesca Bruce
Please Login to read the full article.
15 August 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- Easing of Japanese Tarceva restrictions in NSCLC set to raise pressure on Iressa
- Scotland says yes to BI/Lilly's Tradjenta and Lilly's Bydureon
- Roche pins Tarceva hope on Cancer Drugs Fund after NICE rejects appeal
- Without direct Iressa comparison, NICE wants more on Roche's Tarceva for NSCLC
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
